Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Nature Communications|June 25, 2025
Coordinated early immune response in the lungs is required for effective control of SARS-CoV-2 replicationKlara Lenart, Hendrik Feuerstein, Mariana Prado Marmorato, et al.
Vaccine|September 8, 2019
Evaluation of transcutaneous immunization as a delivery route for an enterotoxigenic E. coli adhesin-based vaccine with CfaE, the colonization factor antigen 1 (CFA/I) tip adhesinJulianne E Rollenhagen, Colleen M Woods, Aisling O'Dowd, et al.
The Journal of Infectious Diseases|July 24, 2004
Induction of protective immunity against lethal anthrax challenge with a patchRichard T Kenney, Jianmei Yu, Mimi Guebre-Xabier, et al.
Vaccine|June 22, 2025
COVID-19 vaccine (NVX-CoV2373 and NVX-CoV2540) doses and virus strain match impact sex- and age-specific immunity and protection in miceSabal Chaulagain, Jaiprasath Sachithanandham, Jennifer A Liu, et al.
Vaccine|November 26, 2019
Maternal immunization with RSV fusion glycoprotein vaccine and substantial protection of neonatal baboons against respiratory syncytial virus pulmonary challengeRobert C Welliver, James F Papin, Alisha Preno, et al.
Vaccines|August 26, 2022
Immune Correlates of Protection from Filovirus Efficacy Studies in Non-Human PrimatesCheryl A Triplett, Nancy A Niemuth, Christopher Cirimotich, et al.
Journal of Virology|September 4, 2024
Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syrian hamstersNadia Soudani, Traci L Bricker, Tamarand Darling, et al.
Vaccine|November 3, 2020
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challengeMimi Guebre-Xabier, Nita Patel, Jing-Hui Tian, et al.
Scientific Reports|November 6, 2023
XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses against EG.5.1 and emerging XBB variantsNita Patel, Jessica F Trost, Mimi Guebre-Xabier, et al.
Nature Communications|July 18, 2025
Single-dose avian influenza A(H5N1) Clade 2.3.4.4b hemagglutinin-Matrix-M<sup>®</sup> nanoparticle vaccine induces neutralizing responses in nonhuman primatesNita Patel, Asma Rehman, Jessica F Trost, et al.
Pageof 3